You are here

  • Home
  • Archive
  • Volume 76, Issue Suppl 2
  • THU0354 Disease worsening and safety in patients switching from originator infliximab to biosimilar infliximab (CT-P13) in the randomized nor-switch-study: explorative analysis in SPA patients

Citation Tools

Article menu

Download PDFPDF

Poster Presentations
Spondyloarthritis - treatment
THU0354 Disease worsening and safety in patients switching from originator infliximab to biosimilar infliximab (CT-P13) in the randomized nor-switch-study: explorative analysis in SPA patients
Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Goll G, Olsen I, Bolstad N, et al
THU0354 Disease worsening and safety in patients switching from originator infliximab to biosimilar infliximab (CT-P13) in the randomized nor-switch-study: explorative analysis in SPA patients
Annals of the Rheumatic Diseases 2017;76:338-339.